You are here

  • Home
  • Archive
  • Volume 12, Issue 2
  • Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations

Article metrics

Article menu
Health services research
Original research
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations

 

Online download statistics by month:

Online download statistics by month: February 2022 to September 2023

AbstractFullPdf
Feb 2022934957164
Mar 202234633499
Apr 202213513451
May 202212611355
Jun 202212612234
Jul 2022757132
Aug 202210210026
Sep 202211411139
Oct 20221059033
Nov 202217916226
Dec 202211811611
Jan 202310310130
Feb 2023625216
Mar 202315214479
Apr 2023655747
May 2023584926
Jun 2023493522
Jul 2023353325
Aug 2023373119
Sep 2023454215
Total29662854849